New research in kidney cancer, ASCO 2017

被引：0
|
作者：
Basappa, Naveen S. [1 ,2 ]
Kapoor, Anil [3 ]
机构：
[1] Cross Canc Inst, Edmonton, AB, Canada
[2] Univ Alberta, Edmonton, AB, Canada
[3] McMaster Univ, Hamilton, ON, Canada
来源：
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL | 2017年 / 11卷 / 08期
关键词：
RENAL-CELL CARCINOMA; SUNITINIB;
D O I：
10.5489/cuaj.4840
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：S298 / S300
页数：3
相关论文
共 50 条
  • [21] Immunotherapy and targeted-therapy combinations mark a new era of kidney cancer treatment
    Zhang, Tian
    George, Daniel J.
    NATURE MEDICINE, 2021, 27 (04) : 586 - 588
  • [22] Management of advanced kidney cancer: Canadian Kidney Cancer Forum 2013 Consensus Update
    North, Scott
    Basappa, Naveen
    Bjarnason, Georg
    Blais, Normand
    Canil, Christina
    Heng, Daniel
    Knox, Jennifer
    Reaume, Neil
    Ruether, Dean
    Soulieres, Denis
    Zalewski, Pawel
    Black, Peter
    Breau, Rodney
    Jewett, Michael
    Kapoor, Anil
    Lattouf, Jean-Baptiste
    Moore, Ronald
    Rendon, Ricardo
    Todd, Gerald
    Pituskin, Edith
    Gedye, Craig
    Wood, Lori
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2013, 7 (7-8): : 238 - 243
  • [23] MicroRNAs: exploring a new dimension in the pathogenesis of kidney cancer
    Nicole MA White
    George M Yousef
    BMC Medicine, 8
  • [24] Antiangiogenics: new therapeutic standards in metastatic kidney cancer
    Cornu, J. -N.
    Roupret, M.
    Bensalah, K.
    Oudard, S.
    Patard, J. -J.
    PROGRES EN UROLOGIE, 2008, 18 : S69 - S76
  • [25] Kidney Cancer Pathology in the New Context of Targeted Therapy
    Allory, Yves
    Culine, Stephane
    de la Taille, Alexandre
    PATHOBIOLOGY, 2011, 78 (02) : 90 - 98
  • [26] Locally Advanced Kidney Cancer: A New Space for Immunotherapy?
    Singla, Nirmish
    Margulis, Vitaly
    EUROPEAN UROLOGY ONCOLOGY, 2022, 5 (01): : 118 - 119
  • [27] Perioperative Approaches to Kidney Cancer
    Iheanacho, Kennedy
    Vaishampayan, Ulka
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (01) : 56 - 65
  • [28] Cabozantinib for the treatment of kidney cancer
    Abdelaziz, Ahmed
    Vaishampayan, Ulka
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (07) : 577 - 584
  • [29] Prognostic factors in kidney cancer and new TNM classification
    Heinzer, Hans
    Eichelberg, Christian
    Heuer, Roman
    Huland, Edith
    Huland, Hartwig
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (05) : 434 - 435
  • [30] New Strategies in Kidney Cancer: Therapeutic Advances through Understanding the Molecular Basis of Response and Resistance
    Rini, Brian I.
    CLINICAL CANCER RESEARCH, 2010, 16 (05) : 1348 - 1354
12345